BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 24, 2018
View Archived Issues
Gene therapy for dominant blindness
Read More
Wee1 is a target in rhabdomyosarcoma
Read More
KW-6356 affects motor scores in phase II early Parkinson's disease trial
Read More
Liver-targeted prodrug may prove effective in fibrosis
Read More
DA-9701 may improve gastric motility in Parkinson's disease patients
Read More
Amgen targets the apelin receptor with AMG-986 for heart failure therapy
Read More
Lenvima approved in Europe as first-line treatment in adults with advanced or unresectable HCC
Read More
Toca 5 pivotal phase III study of Toca-511/Toca-FC continues without modification
Read More
Preclinical data and structure described for next-generation TYK2 inhibitor PF-06826647
Read More
GlaxoSmithKline presents leucine-rich repeat serine/threonine-protein kinase 2 inhibitors
Read More
Yangzhou Blue Biomedical Technology Co. patents penicilone derivatives
Read More
N-acetyl-beta-D-glucosaminidase inhibitors identified at Janssen
Read More
University of South Australia discloses cyclin-dependent kinase inhibitors
Read More
New selective Mcl-1 inhibitors with in vivo activity described by Vanderbilt University
Read More
DSMB completes new review of safety data from FOCUS trial of melphalan/HDS
Read More
FDA approves Takhzyro for prevention of HAE attacks
Read More
FDA approves Diacomit for seizures associated with Dravet syndrome
Read More
Telix submits CTA to begin phase III trial in Europe with TLX-250 for renal cancer imaging
Read More
FDA approves Inveltys for post-operative inflammation and pain
Read More
bluebird bio and Gritstone Oncology establish cancer cell therapy collaboration
Read More
FDA approves cobas EGFR Mutation Test v2 as companion diagnostic test with Iressa
Read More
